Answers are grounded in this paper and cite their sources.
Background: Pediatric sepsis remains a major cause of morbidity and mortality, particularly in low- and middle-income countries. Early risk stratification is important for improving clinical outcomes. Procalcitonin (PCT) has been investigated as a diagnostic and prognostic biomarker in sepsis; however, evidence regarding its role as an independent predictor of mortality in children remains inconsistent. This study aimed to analyze the association between initial procalcitonin levels and mortality in children with sepsis.Methods: This retrospective analytical observational study was conducted at Prof. Ngoerah Hospital, Denpasar, from February 2025 to February 2026. Participants were children aged 1 month to 18 years with suspected infection accompanied by organ dysfunction and positive blood cultures. Initial PCT and blood cultures from two separate sites were obtained within the first 24 hours of admission. Bivariate analyses used the Mann–Whitney and chi-square tests, as appropriate. PCT discrimination was assessed using receiver operating characteristic (ROC) curve analysis, with the optimal cut-off determined by the Youden index. Multivariable logistic regression was used to identify independent predictors of mortality.Results: Fifty-five patients were included; the median age was 36 months (IQR 12–156), and mortality was 45.5%. Median initial PCT was higher among non-survivors than survivors (9.0 [IQR 3.3–42.9] vs. 4.3 [IQR 1.2–39.0] ng/mL), but the difference was not statistically significant (p=0.179). ROC analysis showed limited discrimination (AUC 0.606; 95% CI 0.45–0.75). The optimal cut-off was 3.11 ng/mL, with 80% sensitivity and 46.7% specificity. PCT ≥3.11 ng/mL was associated with mortality and remained independently associated after multivariable adjustment (adjusted OR 4.44; 95% CI 1.04–18.87; p=0.044).Conclusion: Initial PCT levels ≥3.11 ng/mL were independently associated with mortality in children with sepsis. However, its limited discriminative performance indicates that PCT should be interpreted alongside clinical assessment rather than used as a standalone prognostic marker.
No takes yet. Share an insight, caveat, or question.
Hadiyanto et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: